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Dynamics of Envelope Evolution in Clade C SHIV-Infected
Pig-Tailed Macaques during Disease Progression
Analyzed by Ultra-Deep Pyrosequencing
For Yue Tso1., Damien C. Tully1.¤, Sandra Gonzalez1, Christopher Quince6, On Ho2, Patricia Polacino3,
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Abstract
Understanding the evolution of the human immunodeficiency virus type 1 (HIV-1) envelope during disease progression can
provide tremendous insights for vaccine development, and simian-human immunodeficiency virus (SHIV) infection of nonhuman primate provides an ideal platform for such studies. A newly developed clade C SHIV, SHIV-1157ipd3N4, which was
able to infect rhesus macaques, closely resembled primary HIV-1 in transmission and pathogenesis, was used to infect
several pig-tailed macaques. One of the infected animals subsequently progressed to AIDS, whereas one remained a nonprogressor. The viral envelope evolution in the infected animals during disease progression was analyzed by a
bioinformatics approach using ultra-deep pyrosequencing. Our results showed substantial envelope variations emerging in
the progressor animal after the onset of AIDS. These envelope variations impacted the length of the variable loops and
charges of different envelope regions. Additionally, multiple mutations were located at the CD4 and CCR5 binding sites,
potentially affecting receptor binding affinity, viral fitness and they might be selected at late stages of disease. More
importantly, these envelope mutations are not random since they had repeatedly been observed in a rhesus macaque and a
human infant infected by either SHIV or HIV-1, respectively, carrying the parental envelope of the infectious molecular clone
SHIV-1157ipd3N4. Moreover, similar mutations were also observed from other studies on different clades of envelopes
regardless of the host species. These recurring mutations in different envelopes suggest that there may be a common
evolutionary pattern and selection pathway for the HIV-1 envelope during disease progression.
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follow a certain evolutionary pattern during disease progression.
Infection of non-human primates with simian-human immunodeficiency virus (SHIV) would be an ideal platform for investigating
such HIV-1 envelope evolution during disease progression.
SHIV strains have been a significant tool in studying the role of
HIV-1 envelope in pathogenesis and the development of AIDS
vaccines for over a decade. Since their inception, SHIV constructs
have undergone dramatic improvements to recapitulate many of
the features of primary HIV-1 infection when used to infect rhesus
macaques. One such design, SHIV-1157ipd3N4, expresses an R5
tropic HIV-1 clade C envelope isolated from a Zambian infant [4].
In addition, SHIV-1157ipd3N4 is pathogenic and fully capable of
mucosal transmission through multiple routes [4,5]. These
properties closely resemble those of recently transmitted HIV-1

Introduction
The envelope gene of human immunodeficiency virus type 1
(HIV-1) is the most genetically diverse among all HIV-1 genes.
The vital role of HIV-1 envelope in determining cell tropism of the
virus and escape from host immune surveillance made it a logical
choice as the main focus for vaccine development. Thus, a better
understanding of how the envelope evolves during disease
progression could aid in designing better vaccines. Several
envelope mutations, such as increases in the length of V1V2
variable loops and number of potential N-glycosylation sites
(PNGS), have been linked with disease progression in humans
[1,2,3]. Since these mutations were observed in envelopes from
different clades, it would suggest that the envelope might tend to
PLoS ONE | www.plosone.org
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.76106 copies/ml by 2 weeks post-inoculation (Fig. 1B).
However, two infected animals (M04123 and L03165) died due
to unrelated causes during sampling procedures at 2 and 48 weeks
post-inoculation, respectively (data not shown). The remaining
animals (K03135 and J02185) were monitored over a period of 84
weeks. The plasma viral loads of macaque K03135 increased while
its CD4+ T-cell counts declined as disease progressed (Fig. 1A and
B). Macaque K03135 developed AIDS with a CD4+ T-cell count
consistently ,200 cells/ul from 20 weeks post-inoculation
onwards. Therefore, macaque K03135 was classified as a
progressor. Meanwhile, macaque J02185 had normal CD4+ Tcell counts over the entire study period (Fig. 1A). Plasma viral
loads of macaque J02185 fell below the detection limit at 2 weeks
after peak viremia and remained low over the next 82 weeks
(Fig. 1B). Macaque J02185 was still healthy at the end of the study
and was classified as a non-progressor. Both animals maintained a
detectable but gradually declining PBMC proviral DNA load
throughout the course of the disease (Fig. 1C).

isolates, which are mostly R5 tropic and transmitted via mucosal
routes [6,7,8,9]. The fact that SHIV-1157ipd3N4 carries an HIV1 clade C envelope makes this SHIV an important model to study
transmission and pathogenesis of HIV-1 infection in humans:
because more than fifty percent of all HIV-1 infections worldwide
are caused by HIV-1 clade C [10,11].
Until recently, SHIV-1157ipd3N4 had only been utilized to
infect rhesus macaques (Macaca mulatta), a popular animal model
for studying HIV pathogenesis and AIDS vaccine development.
However, there is now a heightened interest in the pig-tailed
macaque (Macaca nemestrina) model. In comparison to rhesus
macaques, pig-tailed macaques are unique as they express a
defective host restriction factor TRIM5a and hence are susceptible
to infection by simian-tropic HIV-1 strains [12,13,14,15]. Given
this recent focus on the pig-tailed macaque animal model, it will be
important to examine the relationship between disease progression
and envelope evolution in pig-tailed macaques infected by SHIV1157ipd3N4. Moreover, this study will help to determine whether
envelope changes observed in a human and in a rhesus macaque
during disease progression are present in this pig-tailed model. In
an earlier report, Ho et al. demonstrated that SHIV-1157ipd3N4
was able to infect pig-tailed macaques by intrarectal inoculation
and to cause AIDS in the infected animal [16]. We procured
samples from these infected pig-tailed macaques and employed
454 ultra-deep pyrosequencing (UDPS) to characterize the HIV-1
clade C envelope changes as the infected animal progressed to
AIDS.
UDPS is a high-throughput sequencing technology that can
rapidly generate a vast amount of sequencing data in a costeffective manner. The high sensitivity of this technology in
detecting minor populations makes it an ideal approach for our
study. UDPS has been used by several groups to study minor drug
resistance mutations, cytotoxic T-lymphocytes (CTL) escape
pathways and small envelope region such as V3
[17,18,19,20,21,22]. To our knowledge, this is the first study to
use UDPS to resolve HIV-1 clade C envelope evolution in infected
pig-tailed macaques during disease progression which is marked
by a consistent decline in CD4+ T-cell count and the present of
high plasma viral load. AIDS is established when the CD4+ T-cell
count falls ,200 cells/ul. By using UDPS, we were able to
quantitatively assess the emergence and outgrowth of minor
variants in the infected animals as the disease progressed and
provide a detailed genetic analysis of such variants. Interestingly,
we found several gp120 mutations that evolved in parallel with
disease progression. In addition, we compared the mutations
observed in the pig-tailed macaque with published data on the
evolution of the precursor envelope of SHIV-1157ipd3N4 in a
rhesus macaque and the Zambian infant, from whom the viral
envelope was originally isolated [23,24]. Our analysis showed that
several shared gp120 mutations were prevalent in the infected
human, rhesus and pig-tailed macaques throughout disease
progression. This study suggests that the HIV-1 clade C envelope
may follow a comparable evolutionary pattern and host selective
pressure during disease progression in infected hosts, regardless of
the host species.

Macaque sample selection and ultra-deep
pyrosequencing of viral envelope
In order to gain a better picture of the envelope changes
throughout disease progression, only animals that underwent a full
84 week course of observation were included for UDPS. For this
purpose, PBMC samples from 5 time points of the progressor
macaque K03135 (2, 16, 44, 64 and 83 weeks post-inoculation)
and non-progressor macaque J02185 (2, 16, 44, 65 and 84 weeks
post-inoculation) were selected for UDPS. In addition, it was
reported previously that there was an unexpected peak of viral
load in the duodenum sample from K03135 at 16 weeks postinoculation [16]. The cause for this sudden elevated viral load in
the gut tissue was unclear. To investigate if there was any unique
viral population residing within the gut tissue at this time point,
additional gut tissue samples from both animals at 16 weeks postinoculation were also included for UDPS. Lastly, the two animals
(M04123 and L03165) that died due to unrelated causes during
sampling procedures were excluded for analysis as it would be
impossible to extrapolate the data from these animals to disease
progression.
The current read length on the GS FLX Titanium series is
approximately 400 bp. In order to cover the regions of interest in
our study, we designed six overlapping PCR amplicons to capture
the viral envelope regions (Fig. 2). Using this approach, we were
able to sequence almost the entire gp120 and through the
transmembrane domain of gp41. From the UDPS, we obtained a
total of 574,225 reads with a median of 43,601 (range 13,964 to
81,666) reads from each sample. The UDPS data were cleaned to
remove reads with PCR and UDPS artifacts while attempting to
retain as many high-quality sequences as possible (see Materials
and Methods). During the initial procedure, a median of 26%
(range 23%–30%) reads were discarded from each sample.
However, after the application of the AmpliconNoise algorithm,
this number increased to a median of 43% (range 34%–47%).
While this number may seem excessively high, there were still on
average 18,000 reads per sample, ensuring sufficiently high
coverage across the envelope to detect minor variants.

Results

Sequence diversity and divergence of intra-host viral
populations

Infection of pig-tailed macaques with SHIV-1157ipd3N4
Detailed examination of the immunological responses of the
infected pig-tailed macaques has been conducted previously [16].
Briefly, after intrarectal inoculation of SHIV-1157ipd3N4, systemic infection was achieved in all four juvenile pig-tailed
macaques with an average peak plasma viral RNA load
PLoS ONE | www.plosone.org

Selective pressures imposed by the host immune system are the
main driving forces shaping the evolutionary dynamics of the viral
envelope. To examine the effect of immune selection on envelope
evolution, we quantified the levels of diversity and divergence for
2
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Figure 1. CD4+ T-cell counts, plasma and PBMC viral loads from infected pig-tailed macaques. (A) Total CD4+ T-cell counts (B) viral RNA
loads in plasma and (C) proviral cDNA loads in PBMC. A scale break (//) representing 8 weeks post-inoculation was insert into the x-axis to show the
early stage of infection. A cross (+) represents death of the animal due to AIDS.
doi:10.1371/journal.pone.0032827.g001

Figure 2. Schematic representation of the envelope regions covered by each amplicon (in reference to Env of the infectious
molecular clone, SHIV-1157ipd3N4).
doi:10.1371/journal.pone.0032827.g002

PLoS ONE | www.plosone.org
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same mutation also developed during disease progression in a
rhesus macaque infected with a clade B SHIV [26].

each amplicon over time in both animals. The non-progressor
macaque J02185 had a relatively low level of diversity in the entire
envelope throughout the course of observation, with a maximum
Shannon diversity index of only 0.72 in amplicon 5 beginning at
16 weeks post-inoculation (Fig. 3A). On the contrary, diversity for
the progressor macaque K03135 began to increase at 44 weeks
post-inoculation. It reached a peak of 2.05 in amplicon 1 and 2.71
in amplicon 3 by 64 weeks post-inoculation (Fig. 3A). The
amplicons that showed a high level of diversity mainly comprised
gp120. A relatively low level of diversity occurred within the gp41
in both animals. Similar to the levels of diversity, the nonprogressor macaque J02185 had low divergence, showing that its
viral populations did not deviate significantly from the inoculum
strain over time, with a highest p-distance of only 0.007 in
amplicon 1 at 65 weeks post-inoculation (Fig. 3B). The divergence
of progressor macaque K03135 had a pattern similar to its
diversity, with a progressively elevated p-distance from 44 weeks
post-inoculation onwards. Amplicons 1 and 3 of the progressor
macaque K03135 showed a high level of deviation from the
inoculum strain, reaching a p-distance of 0.034 and 0.025,
respectively, by 84 weeks post-inoculation (Fig. 3B). Additionally,
the gp41 of K03135 developed a slightly higher divergence than
the other envelope regions at 44 weeks post-inoculation (Fig. 3B).
Mutations in this region might have evolved in response to the host
immune pressure or selection of viral fitness, but there is no
evidence or literature to support these possibilities. Lastly, the
accumulation of minor mutations in gp41 of K03135 did increase
its divergence despite a rather homogenous population over time
as shown in the diversity. For the plasmid control, each of the six
amplicons showed no diversity and a single population was
present.

V1V2 loops
14% and 6.2% of the viral populations contained deletions and
insertions in the V1 loop, respectively, at 64 weeks postinoculation (Fig. 4A). By 83 weeks, .80% of the viral populations
contained an insertion in V1 but only 18.3% contained deletions.
Deletions and insertions in the V1 loop are also common in
human and rhesus macaque (Fig. 5A and Table 1) [24]. While
insertions in the V1 loop usually involved PNGS, many of the
mutations in the V1V2 region comprised of charged amino acids.
The net charge of the V1V2 region for K03135 decreased
significantly over time (P,0.0001) and was strikingly similar to
those observed in the rhesus macaque (Fig. 6A). This charge
reduction in V1V2 region was only observed as the animals
progressed to AIDS.

C2 region
Unlike the highly variable V1V2 region, only 3 non-transient
mutations evolved within C2 region of Env. Among these
mutations, G262E and D273N represent merely 0.9% of the viral
populations at 44 weeks post-inoculation, but subsequently
emerged as the dominant viral population by 64 weeks postinoculation (Fig. 4B). These two mutations had also been observed
in the rhesus macaque during disease progression (Fig. 5B,
Table 1). Interestingly, D273N locates within the CD4 binding site
and mutation at this position may affect envelope binding to CD4.
More importantly, these mutations occurred only after the onset of
AIDS in both the pig-tailed and rhesus macaques.

V3 loop

Envelope evolution through disease progression

The V3 loop of Env was relatively conserved in K03135, except
for S302H that emerged at 44 weeks post-inoculation (Fig. 4B).
Histidine at this position is extremely rare, 0 out of 756 sequences,
in HIV-1 clade C envelope in the HIV sequence database. It is
more commonly found in envelopes from other clades, such as A,
B and D. So far, we had only observed 1 out of 18 HIV-1 clade Cinfected patients from a Zambian cohort with histidine at this
position (unpublished data). Since small changes in this region of
the V3 loop could disturb the stability of the envelope trimeric
structure of and affect CCR5 binding, mutations at this position
could be important [27,28]. Surprisingly, we detected a minor
population of 7.4% in the gut tissue of K03135 at 16 weeks postinoculation that contained a large deletion comprising the regions
of C2V3C3 (Fig. 4B). It was determined that this was not as result
of PCR or UDPS, given that it has passed our strict quality control
procedure and contained an intact open reading frame. At this
point, it is not clear whether this viral population is functional.
However, it was reported previously that an envelope with
truncation in V3 can still be functional [29,30]. In addition, given
that this population was unique to the gut tissue, it might serve as
another example of HIV-1 compartmentalization [31].

In order to further demonstrate the progressive nature of the
diversification of envelope throughout disease progression, we
aligned the amplicons from different time points with their
corresponding reference sequence of the inoculum envelope.
Furthermore, to highlight the similarities of some mutations
observed in the infected pig-tailed macaque with other species, we
included previous sequence data from a study involving the
infected human and rhesus macaque for comparison [24]. In
agreement with the diversity and divergence analysis, alignment of
the amplicons from non-progressor macaque J02185 revealed
extremely low variations within each time point and from the
inoculum envelope (Fig. S1).

C1 region
Contrary to J02185, substantially more mutations were
observed in the progressor macaque K03135 as this animal
progressed to AIDS. Among the mutations in K03135 was S124P,
which evolved from being the minor population at 44 weeks postinoculation to becoming the majority variant by 64 weeks postinoculation (Fig. 4A). S124P is adjacent to the CD4 binding site
and a proline mutation at this position might affect the CD4
binding site structure. Interestingly, the parental envelope of
SHIV-1157ipd3N4 also contains a proline at position 124 [25].
Besides S124P, we also observed the emergence of K130N from
64 weeks post-inoculation onwards (Fig. 4A). K130N resulted in
an additional PNGS and its appearance in the main viral
population coincided with a consistently low CD4 count and the
development of AIDS. More importantly, this identical mutation
was also observed in the human and rhesus macaque during
disease progression (Fig. 5A and Table 1) [24]. In addition, the
PLoS ONE | www.plosone.org

C3 region
The high degree of genetic polymorphism in the a2-helix of C3
had been noted previously in several studies involving human and
rhesus macaque (Fig. 5C) [24,32,33]. The identical region is also
highly variable in K03135 from 64 weeks post-inoculation
onwards (Fig. 4C). Similar to the V1V2 region, mutations in this
region frequently involved charged amino acids. A comparison of
the net charge of C3 revealed a close similarity between the pigtailed and rhesus macaques, with a significant (P,0.0001)
4
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Figure 3. Phylogenetic analysis. (A) Shannon diversity. Longitudinal trends in sequence diversity analyzed using the Shannon Index. Time postinoculation is shown on the x-axis and Shannon Diversity Index values are shown on the y-axis. All data shown are for AmpliconNoise processed
amplicons. (B) Divergence. Longitudinal trends in sequence divergence from the time of inoculation. For direct comparison of sequences the mean
Hamming distance at each time point was measured. Divergence was based on the Hamming distances to the SHIV-1157ipd3N4 inoculum for each

PLoS ONE | www.plosone.org
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amplicon. Time post-inoculation is shown on the x-axis and Hamming distance values are shown on the y-axis. Data for each amplicon are shown
separately with macaque J02185 in red and macaque K03135 in blue, respectively.
doi:10.1371/journal.pone.0032827.g003

precursor envelope sequences of SHIV-1157ipd3N4 (Fig. 5C,
Table 2) [24]. Surprisingly, deletions in V4 were presented at
16.5% of the viral populations from the non-progressor macaque
J02185 at 65 weeks post-inoculation (Fig. S1).

decrease in the C3 charge occurring near the late stage of disease
(Fig. 6B).

V4 loop
85% of the viral populations carried deletions in V4 by 64 weeks
post-inoculation (Fig. 4C). Deletions in V4 had been reported in
pig-tailed macaque infected with a different SHIV [34]. In our
study, the V4 deletions focused on the methionine located at the
tip of V4, which was also progressively eliminated over time in the

C4 region
Despite a high sequence homology in the C4 region of Env,
E415Q and E426A in K03135 emerged from 64 weeks postinoculation onwards (Fig. 4C). E415Q is a significant mutation

Figure 4. Amino acid alignments of the envelope from infected pig-tailed macaque K03135 as represented by ‘‘K’’. (A) Amplicon 1, (B)
Amplicon 2 and (C) Amplicon 3. Weeks post-inoculation is represented by ‘‘wks’’. The value after ‘‘_’’ shows the population number. Deletions in the
alignments are shown as ‘‘-’’. The amount of the particular viral population at that time point is represented as percentage. Point mutations described
in the text are highlighted by red color box.
doi:10.1371/journal.pone.0032827.g004

PLoS ONE | www.plosone.org
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Figure 5. Amino acid alignments of the envelope from infected human (1157i) and rhesus macaque (RPn-8). 1157i and RPn-8 examples
for (A) Amplicon 1, (B) Amplicon 2, (C) Amplicon 3 and (D) V5 loop. The inoculum for RPn-8 was SHIV-1157i (the initial infectious molecular clone).
Weeks post-inoculation or infection is represented by ‘‘wks’’. Sequences presented here are examples from each time point. These are not consensus
sequences and do not represent all the sequence data from both the infected human and rhesus macaque. Point mutations described in the text are
highlighted by red color box.
doi:10.1371/journal.pone.0032827.g005

(Fig. 6C). In addition, this pattern of increasing the charge of C4
resembled that observed in rhesus macaque during disease
progression (Fig. 6C).

since this position is involved in CD4 binding. Surprisingly, the
identical position was also mutated to glutamine over time in
rhesus macaque infected with another SHIV [26]. Similarly,
E426A, a CCR5 binding site, was observed in pig-tailed
macaques, rhesus macaques and human as the disease progressed
(Fig. 5C, Table 2). Since glutamic acid is a negatively charged
amino acid, mutations at these two positions increased the overall
charge of C4 (P,0.0001) as the disease progressed in K03135
PLoS ONE | www.plosone.org

V5 loop and gp41 region
91.6% of the viral populations in K03135 contained deletions in
V5 at 83 weeks post-inoculation (Fig. 7A). Similar deletions were
also observed in rhesus macaque and human over time (Fig. 5D,
7
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Table 1. Comparison of HIV-1 clade C Env mutations between infected pig-tailed (K03135), rhesus macaque (RPn-8) and human
(1157i).

Time points
(post inoculation
or infection)

Amino acid
position
124 (C1)

Amino acid
position
130 (C1)

Deletion
(V1)

Insertion
(V1)

Amino acid
position
262 (C2)

Amino acid
position
273 (C2)

Amino acid
position
302 (V3)

SHIV-1157ipd3N4

S (100%)

K (100%)

0%

0%

G (100%)

D (100%)

S (100%)

K03135 2 weeks

S (100%)

K (100%)

0%

0%

G (100%)

D (100%)

S (100%)

K03135 16 weeks

S (100%)

K (100%)

0%

0%

G (100%)

D (100%)

S (100%)

K03135 16 weeks
gut

S (100%)

K (100%)

0%

0%

G (100%)

D (92.6%)

S (92.6%)

K03135 44 weeks

S (84.2%)/P (15.8%)

K (100%)

0%

0%

G (99.1%)/E (0.9%)

D (99.1%)/N (0.9%)

H (41.6%)

K03135 64 weeks

P (100%)

K (19.5%)/N (80.5%)

14%

6.2%

G (2.9%)/E (97.1%)

D (2.9%)/N (97.1%)

H (100%)

K03135 83 weeks

P (100%)

N (100%)

18.3%

81.3%

E (100%)

N (100%)

H (100%)

1157i 0 week

–

K (100%)

0%

0%

R (96.8%)/W (3.2%)

D (100%)

R (100%)

1157i 26 weeks

–

K (82.7%)/N (6.8%)

37.9%

55.1%

R (100%)

D (100%)

R (100%)

1157i 125 weeks

–

K (19.2%)/N (46.1%)

0%

100%

R (26.9%)/G (73.1%)

D (100%)

R (100%)

1157i 155 weeks

–

K (13.6%)/N (81.8%)

9%

81.8%

R (4.5%)/G (95.5%)

D (100%)

R (100%)

1157i 206 weeks

–

N (100%)

0%

100%

G (100%)

D (100%)

R (100%)

1157i 288 weeks

–

K (15.6%)/
N (18.7%)/T (65.7%)

0%

100%

R (81.2%)/
G (18.8%)

D (100%)

R (65.6%)/K
(31.2%)/G (3.1%)

SHIV-1157i

P (100%)

K (100%)

0%

0%

R (100%)

D (100%)

R (100%)

RPn8 26 weeks

–

K (100%)

0%

0%

R (100%)

D (100%)

R (100%)

RPn8 86 weeks

–

K (100%)

64.5%

0%

R (100%)

D (96.8%)/
G (3.2%)

R (80.6%)/A
(16.1%)/S (3.2%)

RPn8 159 weeks

–

K (100%)

3.3%

0%

R (23.3%)/
G (26.7%)/E (50%)

D (100%)

S (100%)

RPn8 215 weeks

–

K (10%)/N (86.6%)

60%

33.3%

K (3.3%)/
G (3.3%)/E (93.3%)

D (40%)/N (60%)

S (100%)

RPn8 275 weeks

–

N (88.8%)

0%

100%

E (100%)

D (2.8%)/N (97.2%)

S (100%)

Notes:

Adjacent to CD4
binding site

PNGS and charges

PNGS and
charges

PNGS and
charges

CD4 binding site

Amino acid positions are in reference to the SHIV-1157ipd3N4 envelope.
Percentage of viral population containing a particular mutation is shown. ‘‘-’’represent no information.
doi:10.1371/journal.pone.0032827.t001

proviral load occurred in J02185 without any significant decreases
in its CD4+ T-cell counts, suggesting that this reduction was not
due to a lack of target cells. This differs from the observation in the
progressor macaque K03135, whose reduction of PBMC proviral
load coincided with low CD4+ T-cell counts. Together, the data
strongly suggests that cell-mediated immunity, such as cytotoxic T
lymphocyte (CTL) responses, may be responsible for suppressing
viral replication in J02185. However, due to a lack of information
on the MHC class and CTL response analysis of J02185, we can
only postulate that this was the main mechanism for viral control
in this animal, which led to a reduction in virus production and the
number of infected cells. Since mutations occur more frequently
during viral replication, a diminished virus production will
minimize the level of viral genetic variation, thus explaining the
lack of envelope diversity and divergence in J02185 during the
course of observation.
On the contrary, our data showed a very different picture for
the progressor macaque K03135. The high plasma viral RNA
load, PBMC proviral DNA load and decreasing CD4+ T-cell
counts before the development of AIDS, indicated a lack of viral
control by K03135 host responses. Similar to J02185, there were
envelope binding antibodies but no neutralizing antibodies against
SHIV-1157ipd3N4 present in K03135 [16]. Given this lack of
neutralizing antibody responses, there may have been a lack of

Table 2). Lastly, the genetic variability of the envelope decreased
sharply after the V5 loop. We did not find any mutations in the C5
region of the envelope and only few mutations were detected in
gp41 (Fig. 7B and C). However, 1.2% of the viral populations in
the gut tissue of K03135 contained deletions in the heptad repeat 1
of gp41 (Fig. 7C). Given that this deletion happened at such low
frequency and localized in the gut tissue only, the impact of this
mutation had on the overall disease progression could be minimal.

Discussion
In this study, we provided a comprehensive view of the HIV-1
clade C envelope diversifications during disease progression
between progressor and non-progressor pig-tailed macaques.
Despite an extremely low level of diversity and divergence from
the inoculum, we were still able to detect minor envelope variants
in the non-progressor macaque J02185 over time, demonstrating
the value of UDPS. However, there was clearly a mechanism by
which J02185 was able to keep its infection well controlled. The
fact that J02185 had envelope binding antibodies but no
neutralizing antibodies against SHIV-1157ipd3N4, as reported
in the previous study, indicated that neutralizing antibody
responses are not the main mechanism behind its control over
the virus [16]. In addition, the gradual reduction of PBMC
PLoS ONE | www.plosone.org
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Figure 6. Comparison of envelope charges between the infected pig-tailed macaque (K03135) and rhesus macaque (RPn-8). (A) V1V2
regions, (B) C3 region and (C) C4 region. Time points are represented in weeks post-inoculation (wpi). The inoculum SHIV strain for K03135 was SHIV1157ipd3N4 and SHIV-1157i for RPn-8. Each icon represents one envelope sequence.
doi:10.1371/journal.pone.0032827.g006

selective pressure resulting in rapid envelope evolution during the
early phase of infection, thus explaining the low level of envelope
diversity and divergence in K03135 before the development of
AIDS. At the late stage of the disease, perhaps due to the
combined effects of an ablated cellular immune system and natural
selection for viral fitness, there was then a sharp increase in the
envelope diversity and divergence in K03135. The notion that
viral fitness was the main component for natural selection at the
late stage of disease is supported by our observation that the
distribution of envelope variations is not random; with mutations
frequently occurring at specific regions or hotspots throughout the
envelope that are proximal to important receptor binding sites
over time, suggesting the presence of an active selection process.
In our study, we also observed that the envelope tended to
follow a certain evolutionary pattern that correlated with disease
progression. The majority of the envelope mutations were
observed after the onset of AIDS. The most common mutations
involved the addition of PNGS, which usually takes place in highly
variable regions such as V1V2, a2-helix of C3, V4 and V5, and
PNGS have been shown to play an important role in immune
evasion [35,36]. However, since the infected animals in our study
had no neutralizing antibodies against the homologous virus, we
believe these mutations evolved in response to the presence of high

levels of non-neutralizing antibodies [16]. Although non-neutralizing antibodies cannot inhibit viral infection directly, they might
still exert a selective pressure on the viral envelope through
antibody-dependent cell-mediated cytotoxicity (ADCC), as suggested recently during SIV infection [37].
Changes in the length of envelope had been associated with
immune escape and disease progression [1,38]. Our data show
that V1 accounted for the largest increase in length over time,
and coincided with late stages of disease in the infected animals.
There is a close relationship between the higher percentages of
viral populations containing deletions in V4 and V5 with late
stages of disease as well. Furthermore, our study observed a close
association of changes in the envelope charges with disease
progression. For example, the net charge in V1V2 and C3 tended
to increase, while there was a decrease in C4 charges as the
disease progressed. Variations in the charge of envelope had been
suggested to affect viral fitness and were associated with disease
progression [39]. The high number of charged amino acids in the
a2-helix of C3 and its close proximity to the V4 loop suggest that
it could be under heavy selective pressure from the nonneutralizing antibodies [33,40,41]. More importantly, charged
amino acid mutations such as D273N, E415Q and E426A might
affect the receptors binding ability of the envelope. Interestingly,

Table 2. Comparison of HIV-1 clade C Env mutations between infected pig-tailed (K03135), rhesus macaque (RPn-8) and human
(1157i).

Time points
(post inoculation or
infection)

Deletion
(C2V3C3)

a2-helix
(C3)

Deletion
(V4)

Amino acid
position 415
(C4)

Amino acid
position 426
(C4)

Deletion
(V5)

Deletion
(gp41)

SHIV-1157ipd3N4

0%

Non variable

0%

E (100%)

E (100%)

0%

0%

K03135 2 weeks

0%

Non variable

0%

E (100%)

E (100%)

0%

0%

K03135 16 weeks

0%

Non variable

0%

E (100%)

E (100%)

0%

0%

K03135 16 weeks gut

7.4%

Non variable

0%

E (100%)

E (100%)

0%

1.2%

K03135 44 weeks

0%

Non variable

0%

E (78.8%)/Q (21.2%)

E (86.3%)/A (13.7%)

0%

0%

K03135 64 weeks

0%

Variable

85%

E (2.3%)/Q (97.7%)

A (100%)

0%

0%

K03135 83 weeks

0%

Variable

100%

Q (100%)

A (100%)

91.6%

0%

1157i 0 week

0%

Non variable

0%

E (100%)

E (100%)

0%

–

1157i 26 weeks

0%

Non variable

37.9%

E (96.6%)/G (3.4%)

E (100%)

0%

–

1157i 125 weeks

0%

Variable

46.2%

E (100%)

E (26.9%)/A (73.1%)

0%

–

1157i 155 weeks

0%

Variable

95.5%

E (100%)

E (59.1%)/A (40.9%)

0%

–

1157i 206 weeks

0%

Variable

84.6%

E (100%)

E (15.4%)/A (84.6%)

23.1%

–

1157i 288 weeks

0%

Variable

12.5%

E (100%)

E (59.4%)/A (40.6%)

15.6%

–

SHIV-1157i

0%

Non variable

0%

E (100%)

E (100%)

0%

–

RPn8 26 weeks

0%

Non variable

0%

E (100%)

E (100%)

0%

–

RPn8 86 weeks

0%

Non variable

0%

E (100%)

E (29%)/A (71%)

0%

–

RPn8 159 weeks

0%

Variable

60.0%

E (100%)

A (100%)

6.7%

–

RPn8 215 weeks

0%

Variable

10.0%

E (100%)

A (100%)

83.3%

–

RPn8 275 weeks

0%

Variable

88.9%

E (100%)

A (100%)

25.0%

–

PNGS and charges

PNGS

CD4 binding site

CCR5 binding site

PNGS and
charges

Heptad
Repeat 1

Notes:

Amino acid positions are in reference to the SHIV-1157ipd3N4 envelope.
Percentage of viral population containing a particular mutation is shown. ‘‘-’’represent no information.
doi:10.1371/journal.pone.0032827.t002
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Figure 7. Amino acid alignments of the envelope from infected pig-tailed macaque K03135 as represented by ‘‘K’’. (A) Amplicon 4, (B)
Amplicon 5 and (C) Amplicon 6. Weeks post-inoculation is represented by ‘‘wks’’. The value after ‘‘_’’ shows the population number. Deletions in the
alignments are shown as ‘‘-’’. The amount of the particular viral population at that time point is represented as percentage.
doi:10.1371/journal.pone.0032827.g007

variation before AIDS and more genetic variation afterwards.
Such changes are likely due to a lack of immune surveillance in the
early phase and selection for better viral fitness at the late stage of
disease. Additionally, our data suggest that although nonneutralizing antibodies cannot inhibit the virus directly, they
might still contribute to the evolution of envelope. More
importantly, a majority of the mutations and evolutionary patterns
of the envelope witnessed in SHIV-1157ipd3N4-infected pig-tailed
macaques were also common in infected rhesus macaques and
human, thus, suggesting a common selection pathway for the virus
irrespective of the species studied.

similar mutations had been observed with clade A envelope as
well [42].
In our study, we have demonstrated that the use of SHIV1157ipd3N4 in pig-tailed macaque model can mimic the primary
HIV-1 infection and disease progression in the human. Due to
samples availability, we only analyzed PBMC vDNA. While
plasma vRNA is derived from actively replicating virus population,
infected PBMC contain incoming or newly synthesized vRNA in
addition to integrated and unintegrated vDNA. Thus, studying
PBMC allows us to document the complete HIV quasispecies
repertoire which consists of actively replicating and archived
viruses. Moreover, the use of UDPS in this study allowed us to
detect and quantify minority variants that would have gone
unnoticed using conventional sequencing technology. However, a
major challenge with UDPS is its inherent errors that arise during
the pyrosequencing process and those introduced by PCR
amplification. Such errors are typically localized to homopolymers
[43]. Therefore, careful filtering and control is essential to
minimize the possibility of erroneous sequences. We implemented
a carefully designed clean-up strategy to minimize the impact of
454 sequencing errors on interpreting our data. Our denoising
approach removed most pyrosequencing errors due to sporadic
base changes introduced during PCR while attempting to retain
true biological sequence variation. The success of this approach is
measured by our control plasmid amplicons as they were reduced
to a single variant population.
In summary, UDPS has shown a strong association between the
mutational dynamics of envelope and disease progression in the
infected animals. In addition, we found a temporal relationship
between the numbers of mutations occurring with little genetic
PLoS ONE | www.plosone.org

Materials and Methods
Animals and viral stocks
All animals used in this study were housed and cared for
according to the Guide for the Care and Use of Laboratory Animals at the
Washington National Primate Research Center (WaNPRC), an
Association for Assessment and Accreditation of Laboratory
Animal Care International accredited institution. The animal
quarters are maintained at 75–78uF with controlled air humidity
and quality. The home cages of the animals are steam cleaned
bimonthly and the waste pans are cleaned daily. Commercial
monkey chow is fed to the animals once daily and drinking water is
available at all times. Daily examination and any medical care of
the animals are provided by the veterinary staff of WaNPRC in
consultation with the clinical veterinarian. The experimental
procedures were approved by the Institutional Animal Care and
Use Committee (2370-20) at the University of Washington and
conducted in compliance with the Public Health Services Policy
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on Humane Care and Use of Laboratory Animals (http://grants.
nih.gov/grants/olaw/references/PHSPolicyLabAnimals.pdf). The
animals were kept under deep sedation during all procedures with
ketamine HCl at the dose of 10–15 mg/kg intramuscularly to
alleviate any pain and discomfort. The animals were monitored by
the Animal Technician or Veterinary Technologist while under
sedation.
The construction of the infectious molecular clone, SHIV1157ipd3N4, and the preparation of the viral stock were described
previously [4]. All animal procedures and immunological analysis
have also been published [16]. Briefly, four juvenile pig-tailed
macaques were inoculated with SHIV-1157ipd3N4 intrarectally.
Infected animals were monitored over a period of 84 weeks postinoculation. Peripheral blood mononuclear cell (PBMC) and tissue
samples were collected from the infected animals periodically.

PCR conditions used for amplicon amplification were 1 cycle of
95uC for 2 min, 35 cycles of 95uC for 30 sec, 60uC for 30 sec and
72uC for 30 sec and a final extension of 72uC for 4 min. All PCR
was carried out with the FastStart High Fidelity PCR system
(Roche, Indianapolis, IN). PCR products were isolated with the
E.Z.N.A. Gel Extraction Kit (Omega Bio-Tech, Norcross, GA)
and purified by the Agencourt AMPure magnetic beads (Beckman
Coulter Genomics, Danvers, MA) following the conditions
recommended for the Titanium amplicon library preparation
(Roche/454 Life Sciences, Branford, CT). Purified amplicons
were quantitated using the Quant-iT PicoGreen assay kit
(Invitrogen, Carlsbad, CA) and pooled in equimolar concentration
according to the manufacturer’s recommendations. The pooled
amplicons were then processed and sequenced on a Genome
Sequencer FLX (Roche/454 Life Sciences, Branford, CT) at the
Environmental Genomics Core facility (Engencore), Innovista
Research District, University of South Carolina, Columbia, SC.

PCR amplification and amplicon library preparation for
UDPS

UDPS bioinformatics analysis

Genomic DNA from PBMC and gut tissue samples was
extracted following standard protocols. For amplicon library
preparation, the full envelope was amplified from the samples
with first round PCR primers positioned outside the envelope
gene. The envelope from each sample was further amplified into 6
amplicons with six pairs of primers during the second round PCR.
The envelope regions amplified by these primer pairs were
V1V2C2 by primers env1, C2V3C3 by primers env2, V3C3V4C4
by primers env3, C4V5C5-gp41 by primers env4, C5-gp41 by
primers env5 and gp41 by primers env6. Each sample was
barcoded with a specific 10-nucleotides multiplex identifier (MID)
and only primers containing the forward adaptor sequences were
barcoded (Table 3). Two additional primers, env3_F_control and
env3_R_control, were designed to amplify the envelope of an
infectious HIV-1 clade C construct (1084ic) which served as a
control [44]. Primer env1_F was modified to env1_F_a for
amplifying the 65 and 84 weeks post-inoculation samples from
J02185. Sequences of these primers are presented in Table 3. The

The initial sequence reactions yielding 574,225 reads that were
processed to ensure high quality reads to reduce the typical
sequencing errors from 454/Roche pyrosequencing. The data
were cleaned by a set of scripts including the following criteria: (i) a
perfect match to both the barcode and forward primer, (ii) .100
bases in length, and (iii) no undetermined bases (N). The 454 reads
were then separated into samples by amplicons. The flowgrams
corresponding to these reads were extracted, truncated at the first
noisy signal [45], and then filtered to remove any read where this
occurred in the first half of the flowgram. We then applied the
AmpliconNoise pipeline to these samples separately using default
parameters for GSFLX Titanium data [46]. The flowgrams were
clustered with the PyroNoise program to remove 454 sequencing
errors [47]. The forward primer and barcodes were removed from
the resulting sequences, prior to their truncation to 400 bp. These
were clustered with the SeqNoise program to remove PCR errors
[46]. Finally, the Perseus de novo chimera classifier was applied to

Table 3. Primers used for ultradeep-pyrosequencing library preparation.

Primer

Sequence (59-39)a

Genome location

env1_F

cgtatcgcctccctcgcgccatcag-MID-GATGCATGAGGATATAATCAGTTTATGGGA

309–338b

env1_F_a

cgtatcgcctccctcgcgccatcag-MID-CCGGGAAGAGTAATGTTACCTACAAAGGG

404–432b

env1_R

ctatgcgccttgccagcccgctcag-ACATTATGGCATGGTCCTGTCCCA

684–707b

env2_F

cgtatcgcctccctcgcgccatcag-MID-CCTGCTGGTTATGCGATTCTAAA

640–662b

env2_R

ctatgcgccttgccagcccgctcag-CAATAGAAAAATTCTCCTCTACAATTAAA

1102–1130b

env3_F

cgtatcgcctccctcgcgccatcag-MID-ACCAGGACAAGCAATCTATGCCAC

912–935b

env3_R

ctatgcgccttgccagcccgctcag-TCCTCCAGGCCTGAATGTTTCTGT

1357–1380b

env3_F_control

cgtatcgcctccctcgcgccatcag-MID-ATGAGGATAGGACCAGGACAAGCA

892–915c

env3_R_control

ctatgcgccttgccagcccgctcag-TCCTCCCGGTCTGAATATCTCTGT

1321–1344c

env4_F

cgtatcgcctccctcgcgccatcag-MID-TAAACATGTGGCAGGAGGTAGGAC

1229–1252b

env4_R

ctatgcgccttgccagcccgctcag-ATTGATGCTGCGCCCATAGTGCT

1546–1568b

env5_F

cgtatcgcctccctcgcgccatcag-MID-TGGAGGAGGAGATATGAGGGACAA

1374–1397b

env5_R

ctatgcgccttgccagcccgctcag-TACTCCAACTGTCGTTCCAAGGCA

1787–1810b

env6_F

cgtatcgcctccctcgcgccatcag-MID-TGGGGCATTAAGCAGCTC

1675–1692b

env6_R

ctatgcgccttgccagcccgctcag-CGATAATGGTGAGTATCCCTGCCT

2089–2112b

a

lower-case letters: 59 extensions for forward and reverse adaptor sequences; MID: 10-bp multiplex identifier; capital letters: envelope specific sequences.
In reference to the envelope of the infectious molecular clone SHIV-1157ipd3N4 (GenBank: DQ779174.1).
In reference to the envelope of the HIV-1 isolate HIV1084i (GenBank: AY805330.1).
doi:10.1371/journal.pone.0032827.t003

b
c
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screen the sequences for chimeric PCR products which were then
removed, giving denoised chimera checked sequences that were
used in the following analysis. Alignments were generated and
manually inspected to ensure any remaining variants with
frameshifts or stop codons were removed. After the automated
cleanup, a small number of problematic sequences remained that
were associated with indels in homopolymer tracts. We modified
these errors by deleting the extra base or adding a missing base
relative to the inoculum sequence. As a control for 454 sequencing
errors, a plasmid containing a subtype C envelope, 1084ic, was
amplified and processed in parallel to the samples.

Envelope charge analysis
The charge of the envelope was calculated with AminoTrackTM
[50]. Briefly, arginine and lysine have a charge of +1, while
aspartic acid and glutamic acid have a charge of 21. Statistical
analysis was calculated using GraphPad Prism 5 (GraphPad
Software, Inc., San Diego, CA).

Supporting Information
Amino acid alignments of the envelope from
infected pig-tailed macaque J02185 as represented by
‘‘J’’. (A) Amplicon 1, (B) Amplicon 2, (C) Amplicon 3, (D)
Amplicon 4, (E) Amplicon 5 and (F) Amplicon 6. Weeks postinoculation is represented by ‘‘wks’’. The value after ‘‘_’’ shows the
population number. Deletions in the alignments are shown as ‘‘-’’.
The amount of the particular viral population at that time point is
represented as percentage.
(TIF)

Figure S1

Sequence diversity and divergence of intra-host virus
populations
Diversity of viral sequences for each time point within each
monkey was calculated using the Shannon Diversity Index. as
follows

H’~{

R
X
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where H9 is the Shannon Diversity Index, R is the total number of
species encountered and Pi represents the fraction of the entire
population made up of species i [48]. Divergence of viral
sequences for each time point within each monkey was calculated
as the genetic distance between each sequence and the inoculum
strain as calculated in MEGA v5.0 [49].
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